Hualin Tao

Hualin Tao

Auto-generated profile, based on publicly available information

Hualin Tao

The Affiliated Hospital of Southwest Medical University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YJYao Jiang
Yao Jiang
JHJimin He
Jimin He
YGYongcan Guo
Yongcan Guo
HTHualin Tao
Hualin Tao
FPFei Pu
Fei Pu
YLYiqin Li
Yiqin Li

10 November 2014 in Oncology Letters
Verified
Journal Article
Open access
PDF file
XZXiaojun Zeng
Xiaojun Zeng
HTHualin Tao
Hualin Tao
Cholangiocarcinoma (CCA) is a fatal disease that is typically diagnosed late and treated ineffectively. As the morbidity and mortality rates for CCA rise markedly, patietns with CCA currently have a poor prognosis. However, if it were possible to diagnose CCA early while effective treat methods are available, CCA patients would achieve a better quality of life. Therefore, preventing the process of CCA in the early stages is an urgent problem to solve. An accurate, quick and safe method to diagnose early‑stage CCA is required. The present review discusses the risk factors, status of research and certain serum markers of CCA. The sensitivity and specificity of these markers differ from each other. To explore the more accurate serum markers may be a novel direction and method for the diagnosis of CCA in laboratory medicine in the future.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YJYao Jiang
Yao Jiang
ZHZuohong Hu
Zuohong Hu
ZZZhihua Zuo
Zhihua Zuo
YLYiqin Li
Yiqin Li
FPFei Pu
Fei Pu
HTHualin Tao
Hualin Tao
Background. Cervical cancer (CC) is one of the most common female malignant tumors. And cervical intraepithelial neoplasia (CIN) is the precancerous lesion of CC, which can progress to invasive CC. MicroRNAs (miRNAs) have been found to be potential diagnostic biomarkers for CIN or CC. However, recently, the lack of sufficient studies about the diagnostic value of miRNAs for CIN made it challenging to separately investigate the diagnostic efficacy of miRNAs for CIN. Likewise, the conclusions among those studies were discordant. Therefore, we conducted this meta‐analysis, aimed at evaluating the diagnostic efficacy of miRNAs for CIN and CC patients. Methods. Literature search was performed in PubMed, Embase, and Web of Science databases. Pooled sensitivity, specificity, and other diagnostic parameters were calculated through Stata 14.0 software. Furthermore, subgroup analyses and metaregression analysis were conducted to explore the main sources of heterogeneity. Results. Ten articles covering 50 studies were eligible, which included 5,908 patients and 4,819 healthy individuals. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) were 0.81 (95% CI, 0.77‐0.85), 0.86 (95% CI, 0.83‐0.89), 5.9 (95% CI, 4.5‐7.7), 0.22 (95% CI, 0.17‐0.28), 27 (95% CI, 17‐44), and 0.91 (95% CI, 0.88‐0.93), respectively. Additionally, the ethnicity and internal reference were the main sources of heterogeneity. Conclusions. Circulating miRNAs can be a promising noninvasive diagnostic biomarker for CIN and early CC, especially miR‐9 and miR‐205, which need to be verified by large‐scale studies.

1 May 2020 in Clinica Chimica Acta
Verified
Journal Article
Closed access
PZPan Zhou
Pan Zhou
JYJia-Xin Yin
Jia-Xin Yin
HTHua-Lin Tao
Hua-Lin Tao
HZHong-Wei Zhang
Hong-Wei Zhang

1 October 2020 in Pathology - Research and Practice
Verified
Journal Article
Closed access
ZZZhihua Zuo
Zhihua Zuo
YJYao Jiang
Yao Jiang
SZShanshui Zeng
Shanshui Zeng
YLYiqin Li
Yiqin Li
JFJia Fan
Jia Fan
HTHualin Tao
Hualin Tao

7 December 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
ZZZhihua Zuo
Zhihua Zuo
YLYiqin Li
Yiqin Li
CZChuyi Zeng
Chuyi Zeng
YXYuge Xi
Yuge Xi
HTHualin Tao
Hualin Tao
YGYongcan Guo
Yongcan Guo
Background: Alcoholic liver disease (ALD) is one of the most common chronic liver diseases worldwide. However, the potential molecular mechanism in ALD development remains unclear. The objective of this work was to identify key molecules and demonstrate the underlying regulatory mechanisms.Methods: RNA-seq datasets were obtained from Gene Expression Omnibus (GEO), and key molecules in ALD development were identified with bioinformatics analysis. Alcoholic liver disease mouse and cell models were constructed using Lieber-DeCarli diets and alcohol medium, respectively. Quantitative real-time PCR and Western blotting were conducted to confirm the differential expression level. Dual-luciferase reporter assays were performed to explore the targeting regulatory relationship. Overexpression and knockdown experiments were applied to reveal the potential molecular mechanism in ALD development.Results: Between ALD patients and healthy controls, a total of 416 genes and 21 microRNAs (miRNAs) with significantly differential expression were screened. A comprehensive miRNA-mRNA network was established; within this network, the miR-182-5p/FOXO1 axis was considered a significant pathway in ALD lipid metabolism. Mouse and cell experiments validated that miR-182-5p was substantially higher in ALD than in normal livers, whereas the expression of FOXO1 was dramatically decreased by alcohol consumption (P < 0.05). Next, dual-luciferase reporter assays demonstrated that miR-182-5p directly targets the binding site of the FOXO1 3′UTR and inhibits its mRNA and protein expression. In addition, miR-182-5p was found to promote hepatic lipid accumulation via targeting the FOXO1 signaling pathway, and inhibition of the miR-182-5p/FOXO1 axis improved hepatic triglyceride (TG) deposition in ALD by regulating downstream genes involved in lipid metabolism.Conclusion: In summary, key molecules were identified in ALD development and a comprehensive miRNA–mRNA network was established. Meanwhile, our results suggested that miR-182-5p significantly increases lipid accumulation in ALD by targeting FOXO1, thereby providing novel scientific insights and potential therapeutic targets for ALD.